possible link between atypical antipsychotics and diabetes

November 2003

You'll see more attention focused on the possible link between atypical antipsychotics and diabetes.

FDA and drug companies will battle out new labeling requirements for warnings about diabetes risks in patients taking atypicals.

The FDA wants the warnings to apply to ALL atypicals. But some companies don't think their drug needs the new warning at all.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote